Last updated 14 days ago

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

390 patients around the world
Available in Chile, United States
Biohaven Therapeutics Ltd.
1Research sites
390Patients around the world
This study is for people with
Epilepsies
Epilepsy
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Centro Médico Vanguardia
Recruiting
Dieciocho de Septiembre 525, Of 403, 4810345 Temuco, Araucanía, Chile
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy